In Nov. 2022, the U.S. nonprofit Multidisciplinary Affiliation for Psychedelic Studies (MAPS) announced that it had done a 2nd phase-a few demo on MDMA as being a therapy for PTSD—a step greatly viewed as the final https://keiranzccv543821.therainblog.com/profile